National Pain Centre Receives Funding for Opioid Guideline Revision
![Feature image](https://healthsci.mcmaster.ca/wp-content/uploads/2023/07/pin_shadow.png)
Health Canada's Substance Use and Addictions Program (SUAP) provides funding for critical updates to the Opioid Guidelines for Non-Cancer Chronic Pain.
Health Canada’s Substance Use and Addictions Program (SUAP) has awarded the National Pain Centre $545,977, over the course of 18 months, to update the 2017 Canadian Guideline on the use of opioids for non-cancer pain, incorporating new evidence and adopting new knowledge synthesis methods, as well as incorporating information from stakeholder feedback. The updated guideline will provide essential information to people living with chronic pain, and physicians, nurse practitioners, and pharmacists involved in their care.
Canadians are the second highest users per capita of opioids in the world. The 2017 Canadian Guideline for Opioid for Chronic Non-Cancer Pain was developed to optimize evidence-based prescribing of opioids for chronic non-cancer pain and recommendations for clinical practice were developed by an international team of clinicians, researchers and patients.
Work on the revised guideline has already begun and will be completed in 2023.
Related News
News Listing
![](https://healthsci.mcmaster.ca/wp-content/uploads/2023/07/trophy_shadow.png)
Deadline for 2023 IPRC Awards approaching
Michael G. DeGroote Institute for Pain Research, National Pain Centre
October 25, 2022
![](https://healthsci.mcmaster.ca/wp-content/uploads/2023/07/untitled-design-50.png)
Health Sciences researchers pay tribute to Michael G. DeGroote
Dept. HEI - Main, FHS, In Memoriam, Michael G. DeGroote Institute for Pain Research, Research
September 16, 2022
![](https://healthsci.mcmaster.ca/wp-content/uploads/2023/07/halfresearchday.jpg)
Institute for Pain Research & Care Announces Date for Half Research Day
Michael G. DeGroote Institute for Pain Research, National Pain Centre
September 5, 2022